Zobrazeno 1 - 10
of 39
pro vyhledávání: '"Wei Fang Dai"'
Autor:
Brandon Lu, Wei Fang Dai, Ruth Croxford, Wanrudee Isaranuwatchai, Jaclyn Beca, Ines B. Menjak, Teresa M. Petrella, Nicole Mittmann, Craig C. Earle, Scott Gavura, Rebecca E. Mercer, Timothy P. Hanna, Kelvin K. W. Chan
Publikováno v:
Cancer Medicine, Vol 12, Iss 10, Pp 11451-11461 (2023)
Abstract Background The efficacy‐effectiveness gap between randomized trial and real‐world evidence regarding the clinical benefit of ipilimumab for metastatic melanoma (MM) has been well characterized by previous literature, consistent with init
Externí odkaz:
https://doaj.org/article/f0604d85f42d4d3396b6316504533bac
Autor:
Ambica Parmar, Wei Fang Dai, Francois Dionne, Marc Geirnaert, Avram Denburg, Tarry Ahuja, Jaclyn Beca, Sylvie Bouchard, Carole Chambers, Melissa J. Hunt, Don Husereau, Elena Lungu, Valerie McDonald, Rebecca E. Mercer, Gunita Mitera, Caroline Muñoz, Rohini Naipaul, Stuart Peacock, Tanya Potashnik, Mina Tadrous, Pam Takhar, Marianne Taylor, Maureen Trudeau, Danica Wasney, Scott Gavura, Kelvin K. W. Chan
Publikováno v:
Current Oncology, Vol 30, Iss 4, Pp 3776-3786 (2023)
The Canadian Real-world Evidence for Value of Cancer Drugs (CanREValue) collaboration developed an MCDA rating tool to assess and prioritize potential post-market real-world evidence (RWE) questions/uncertainties emerging from public drug funding dec
Externí odkaz:
https://doaj.org/article/4fb575f2c14545e7887f622958f92f21
Autor:
Wei Fang Dai, Claire de Oliveira, Scott Blommaert, Reka E. Pataky, David Tran, Zeb Aurangzeb, Cynthia Kendell, Chris Folkins, Chandy Somayaji, Jeff Dowden, Winson Cheung, Erin Strumpf, Jaclyn M. Beca, Carol McClure, Robin Urquhart, James Ted McDonald, Riaz Alvi, Donna Turner, Stuart Peacock, Avram Denburg, Rebecca E. Mercer, Caroline Muñoz, Ambica Parmar, Mina Tadrous, Pam Takhar, Kelvin K. W. Chan, on behalf of the CanREValue Collaboration
Publikováno v:
Current Oncology, Vol 29, Iss 3, Pp 2046-2063 (2022)
Canadian provinces routinely collect patient-level data for administrative purposes. These real-world data (RWD) can be used to generate real-world evidence (RWE) to inform clinical care and healthcare policy. The CanREValue Collaboration is developi
Externí odkaz:
https://doaj.org/article/b4db62942dc7480d850936adb09a42d1
Autor:
Wei Fang Dai, Erica Craig, Brent Fraser, Alex Chambers, Helen Mai, M. Bryson Brown, Craig C. Earle, William K. Evans, Marc Geirnaert, Marianne Taylor, Maureen Trudeau, Daniel Sperber, Jaclyn M. Beca, Avram Denburg, Rebecca E. Mercer, Ambica Parmar, Mina Tadrous, Pam Takhar, Kelvin K. W. Chan, on behalf of the CanREValue Collaboration
Publikováno v:
Current Oncology, Vol 28, Iss 6, Pp 4645-4654 (2021)
The CanREValue Collaboration established the Reassessment & Uptake Working Group to develop a preliminary process to reassess funded cancer drugs in Canada. A simulated exercise was conducted to evaluate the proposed reassessment process using a real
Externí odkaz:
https://doaj.org/article/524acb9fb32b4ff39d6c84874e0c7e30
Autor:
Wei Fang Dai, Vanessa Arciero, Erica Craig, Brent Fraser, Jessica Arias, Darryl Boehm, Nevzeta Bosnic, Patricia Caetano, Carole Chambers, Barry Jones, Elena Lungu, Gunita Mitera, Tanya Potashnik, Anthony Reiman, Trevor Ritcher, Jaclyn M. Beca, Avram Denburg, Rebecca E. Mercer, Ambica Parmar, Mina Tadrous, Pam Takhar, Kelvin K. W. Chan, on behalf of the CanREValue Collaboration Reassessment and Uptake Working Group
Publikováno v:
Current Oncology, Vol 28, Iss 5, Pp 4174-4183 (2021)
The Canadian Real-world Evidence for Value in Cancer Drugs (CanREValue) Collaboration was established to develop a framework for generating and using real-world evidence (RWE) to inform the reassessment of cancer drugs following initial health techno
Externí odkaz:
https://doaj.org/article/9c275cad03714dd78f5a9502b73ba44d
Autor:
Steven Habbous, Helen Guo, Jaclyn Beca, Wei Fang Dai, Wanrudee Isaranuwatchai, Matthew Cheung, Kelvin K. W. Chan
Publikováno v:
Cancer Medicine, Vol 9, Iss 19, Pp 7072-7082 (2020)
Abstract Introduction For patients with diffuse large B‐cell lymphoma (DLBCL), standard‐care is rituximab administered with CHOP or CHOP‐like chemotherapy (R‐CHOP). However, the effectiveness and safety of R‐CHOP among DLBCL patients with h
Externí odkaz:
https://doaj.org/article/54695a5e41164855a1f9226db5962c5d
Autor:
Wei Fang Dai, Jaclyn M. Beca, Ruth Croxford, Wanrudee Isaranawatchai, Ines B. Menjak, Teresa M. Petrella, Nicole Mittmann, Craig C. Earle, Scott Gavura, Timothy P. Hanna, Kelvin K.W. Chan
Publikováno v:
BMC Cancer, Vol 20, Iss 1, Pp 1-10 (2020)
Abstract Background For novel cancer treatments, effectiveness in clinical practice is not always aligned with clinical efficacy results. As such it is important to understand a treatment’s real-world effectiveness. We examined real-world populatio
Externí odkaz:
https://doaj.org/article/8e1d20f0fb0e4de2a3680b817b76c7b2
Autor:
Wei Fang Dai, Jaclyn Beca, Helen Guo, Wanrudee Isaranawatchai, Deborah Schwartz, Rohini Naipaul, Jessica Arias, Yao Qiao, Scott Gavura, Ruby Redmond‐Misner, Zahra Ismail, Lisa Barbera, Kelvin Chan
Publikováno v:
Cancer Medicine, Vol 9, Iss 1, Pp 215-224 (2020)
Abstract Background Advanced pancreatic cancer (APC) patients often have substantial symptom burden. In Ontario, patients routinely complete the Edmonton Symptom Assessment Scale (ESAS), which screens for nine symptoms (scale: 0‐10), in cancer clin
Externí odkaz:
https://doaj.org/article/03194fd351b741d29c73b8bcdebf1b26
Autor:
Reka E. Pataky, Jaclyn Beca, David Tran, Wei Fang Dai, Erind Dvorani, Wanrudee Isaranuwatchai, Stuart Peacock, Riaz Alvi, Winson Y. Cheung, Craig C. Earle, Scott Gavura, Kelvin K. W. Chan
Publikováno v:
MDM Policy & Practice, Vol 6 (2021)
Background. Real-world evidence can be a valuable tool when clinical trial data are incomplete or uncertain. Bevacizumab was adopted as first-line therapy for metastatic colorectal cancer (mCRC) based on significant survival improvements in initial c
Externí odkaz:
https://doaj.org/article/bf453391baff492eb408bacb74c46018
Publikováno v:
University of Toronto Medical Journal. 2022 Supplement, Vol. 99, p1-113. 113p.